References
- McManus P, Mant A, Mitchell P B, Montgomery W S, Marley J, Auland M E. Recent trends in the use of antidepressant drugs in Australia, 1990–98. Medical Journal of Australia 2000; 173: 458–461
- Commonwealth Department of Health and Aged Care. Australian Statistics on Medicines, 1998. AusInfo, Canberra 1999
- Hurley S F, McNeil J J, Berbatis C G. Sources of Australian pharmacoepidemiology data. Community Health Studies 1988; 12: 82–96
- World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs, 1999. WHO, Oslo 1998
- World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment2nd edn. WHO, Oslo 1998
- StataCorp. Stata statistical software: release 6.0. Stata Corporation, College Station, TX 1999
- Britt H, Sayer G P, Miller G C, et al. General practice activity in Australia, 1998–1999. Australian Institute of Health and Welfare, Canberra 1999, Cat. No. GEP 2
- Sayer G P, Britt H, Horn F, et al. Measures of health and health care delivery in general practice in Australia. Australian Institute of Health and Welfare, Canberra 2000, Cat No. GEP 3
- American Psychiatric Association. Diagnostic and statistical manual of disorders4th edn. American Medical Association, Washington, DC 1994
- McManus P, Mant A, Mitchell P, Birkett D, Dudley J. Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it?. British Journal of Clinical Pharmacology 2001; 51: 93–98